Abstract:Objective To investigate the expression of insulin-like growth factor Ⅱ mRNA binding protein 3 (IMP3) in non-muscle invasive bladder cancer and its relationship with the tumor recurrence and progression.Methods IMP3 protein expression was detected by immunohistochemistry in 130 cases of nonmuscle invasive bladder cancer specimens who underwent transurethral resection the first time at Beijing Chao-Yang hospital,from October 2010 to October 2013.Besides,we analyzed 20 cases of muscle-invasive samples and 20 benign tissues adjacent to cancer as control.The 130 patients were followed up by telephone and other methods.According to the UICC-TNM standard.Survival analysis was calculated by using the Kaplan-Meier method,and the difference in survival curves was analyzed by using the log-rank test.For multiple analyses,The Cox proportional hazards regression model was used.Results The positive expression rate of IMP3 in 130 patients with non-muscle invasive bladder cancer was 59.2％ (77/130),of which 30.0％ (39/130) was weak expression,29.2％ (38/130) was strong.However there was 80.0％ (16/20) in muscle-invasive specimens,of which 20.0％ (4/20) was weak,60.0％ (12/20) was strong (P =0.011).IMP3 was not detected in all benign tissues adjacent to cancer (P ＜0.001).All the 130 patients were followed-up for 5 to 69 mnonths,45 cases experienced disease recurrence,20 patients had progressed and 12 cases died.IMP3 expression was significantly related to higher tumor stage (P ＜ 0.001),high tumor grade (P =0.014),and tumor recurrence (P =0.003).Kaplan-Meier plots and log-rank tests showed that patients with IMP3-positive tumors had a lower disease-free survival (P =0.002) and progression-free survival rate (P =0.010) than those with IMP3-negative tumors.In the multivariable Cox analysis,we found that IMP3 protein was an independent predictor of disease-free survival (P =0.010) in non-muscle invasive urothelial carcinoma of bladder.Conclusions IMP3 was not expressed in benign tissue adjacent to cancer,whereas highly expressed in bladder cancer,and high IMP3 expression is an independent prognostic factor in NMIBC that can identify the patients with a high potential to relapse.

IMP3 Is a Novel Prognostic Marker that Correlates with Colon Cancer Progression and Pathogenesis

Expression of Insulin-Like Growth Factor- II Mrna-Binding Protein 3 in Colon Cancer and Its Implication

Insulin-like Growth Factor-Ii Mrna-Binding Protein 3 Predicts a Poor Prognosis for Colorectal Adenocarcinoma

Prognostic value of high IMP3 expression in solid tumors: a meta-analysis.

Effect of IMP3 on Epithelial-to-mesenchymal Transition and the Function of Colon Cancer Stem Cells.

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Clinical Implications of Insulin-Like Growth Factor II Mrna-Binding Protein 3 Expression in Non-Small Cell Lung Carcinoma

IMP3 Expression and Its Relationship with Clinicopathological Characteristics in Breast Carcinoma

IMP3 is a Biomarker for Non-Muscle-invasive Urothelial Carcinoma of the Bladder Associated with an Aggressive Phenotype.

Expression of insulin-like growth factor 2 mRNA-binding protein 3 expression and analysis of prognosis in the patients with lung squamous cell carcinoma]

Prognostic significance of insulin-like growth factor-II mRNA-binding protein 3 in urological cancers: a systemic review and meta-analysis

IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma.

IMP3 Expression in Biopsy Specimens As a Diagnostic Biomarker for Colorectal Cancer.

Insulin-like Growth Factor Ⅱ Mrna Binding Protein 3 Expression in the Non-Muscle Invasive Bladder Cancer and Its Relationships with the Prognosis

RNA-binding protein IMP3 is a novel regulator of MEK1/ERK signaling pathway in the progression of colorectal Cancer through the stabilization of MEKK1 mRNA

The Correlation Between Insulin-Like Growth Factor Ii Mrna Binding Protein 3 Expression in Hepatocellular Carcinoma and Prognosis

The Role of PEG3 in the Occurrence and Prognosis of Colon Cancer.

Prognostic Value of the IASLC/ATS/ERS Classification and IMP3 Expression in Lung Adenocarcinoma of Chinese Cases.

Effects of PIM3 in Prognosis of Colon Cancer

Tip30/Cc3 Expression in Breast Carcinoma: Relation to Metastasis, Clinicopathologic Parameters, and P53 Expression

Expression of Pim-3 in colorectal cancer and its relationship with prognosis